Clinical Trial Update: Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis* [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating whether a booster dose of Gardasil-9 improves intersurgical intervals in adults with recurrent respiratory papillomatos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Papillomatosis

Drugs mentioned

• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Ohio State University | Conditions: Recurrent Respiratory Papillomatosis (RRP) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING